Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Tinea Pedis: full-pipeline trial registry
1 of 10 indexed Tinea Pedis trials are currently recruiting.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 1 currently recruiting · #1,724 of 28,707 conditions by registered trial count
Tinea Pedis: 10 US clinical trials tracked, 1 recruiting.
Tinea Pedis is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is AmDerma, running 2 of these trials.
Enrollment posture brief
Registry condition tinea-pedis
OPEN 1 | RECR 10% | LATE 4 | EARLY 5 | RANK #1724 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Angina Pectoris (10% recruiting · 10 trials)
Tinea Pedis lists 1 open slots (10% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Tinea Pedis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Tinea Pedis is recruiting below its size-band peers.
1 of 10 indexed trials (10%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Tinea Pedis research.
AmDerma accounts for 2 of 10 trials (20%). 9 distinct sponsors appear on at least one study for this condition label.
-
Typical Tinea Pedis enrolment sits around 160 participants.
Median target enrolment is 160 among the 10 trials that report a genuine target (sentinel values excluded). 3 of those (30%) plan for fewer than 100 participants.
-
Tinea Pedis research is mostly interventional.
9 interventional and 1 observational studies make up this index (90% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study
Propedix
NCT07245667
BE Study of Naftifine HCL
Genzum Life Sciences
NCT02633813
A Therapeutic Equivalence Study of Ketoconazole Cream 2%
Douglas Pharmaceuticals America
NCT04203342
Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis
Tinea Pharmaceuticals
NCT01349998
Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis
AmDerma
NCT01358240
A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.
Sun Pharmaceutical Industries
NCT04883593
A Study of Econazole Foam 1% in Athlete's Foot
AmDerma
NCT00768599
Three-Arm Trial of Novel Treatment for Tinea Pedis
South End Skin Care
NCT03135912
Spread of Dermatophytes Among Families
University Hospitals Cleveland Medical Center
NCT00233493
Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis
Therapeutics
NCT05363449
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 3 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Tinea Pedis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Tinea Pedis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Tinea Pedis page
10 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Tinea Pedis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- AmDerma sponsors the most Tinea Pedis trials on record, review their full trial history before evaluating a specific study. See AmDerma's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tinea Pedis condition card totals 10 registered trials; most-linked intervention Vehicle Foam; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.